MedTrace Logo

Up-Down Determination of the ED90 of Metaraminol to Treat Hypotension During Cesarean Section

NCT01108874 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2010-10-01

No results posted yet for this study

Summary

The purpose of this study is to find the best dose of metaraminol to be used in patients during elective cesarean sections.

Conditions

Interventions

DRUG

Metaraminol

Patients will be given metaraminol every time SBP falls below baseline value.

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Jefferson Clivatti, MD · Disciplina de Anestesiologia, UNIFESP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108874 on ClinicalTrials.gov